Drugs that target pathogen public goods are robust against evolved drug resistance

Evolutionary Applications

Volumn 5, Issue 7, 2012, Pages 757-761

  Pepper, John W ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SANTA FE INSTITUTE   (United States)

Author keywords

Biomedicine; Cancer medicine; Contemporary evolution; Disease biology; Evolutionary medicine; Evolutionary theory; Experimental evolution; Microbial biology; Natural selection

Indexed keywords

EID: 84868244170     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/j.1752-4571.2012.00254.x     Document Type: Article

References (18)

1. Adami, C., and C. O. Wilke 2004. Experiments in digital evolution (editors' introduction to the special issue). Artificial Life10:117-122.
2. Andre, J. B., and B. Godelle 2005. Multicellular organization in bacteria as a target for drug therapy. Ecology Letters8:800-810.
3. Driscoll, W. W., and J. W. Pepper 2010. Theory for the evolution of diffusible external goods. Evolution64:2682-2687.
4. El'Garch, F., K. Jeannot, D. Hoccluet, C. Llanes-Barakat, and P. Plesiat 2007. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrobial Agents and Chemotherapy51:1016-1021.
5. Fong, I. W., and K. Drlica, eds. 2003. Reemergence of established Pathogens in the 21st Century. Kluwer, New York.
6. Hamilton, W. D. 1975. Innate social aptitudes of man: an approach from evolutionary genetics. In F. R. Robin Fox, ed. Biosocial Anthropology, pp. 133-153. Malaby Press, London, UK.
7. Lee, Henry H., N. Michael Molla, R. Charles Cantor, and J. James Collins 2010. Bacterial charity work leads to population-wide resistance. Nature467:82-U113.
8. Moscow, Jeffrey, Charles, Morrow, and Kenneth, Cowan. 2003. Drug Resistance and its Clinical Circumvention. In Cancer Medicine 6, edited by D.W. Kufe, R.E. Pollack, R.R. Weichselbaum, R.C. Bast Jr., T.S. Gansler, J.F. Holland and E. Frei III. Hamilton: BC Decker Inc.
9. O'Connor, R., M. Clynes, P. Dowling, N. O'Donovan and L. O'Driscoll 2007. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents. Expert Opinion on Drug Metabolism & Toxicology 3 (6):805-817.
10. Okasha, S. 2004. The "averaging fallacy" and the levels of selection. Biology and Philosophy19:167-184.
11. Pennock, R. T. 2007. Models, simulations, instantiations, and evidence: the case of digital evolution. Journal of Experimental and Theoretical Artificial Intelligence19:29-42.
12. Pepper, J. W. 2007. Simple models of assortment through environmental feedback. Artificial Life13:1-9.
13. Pepper, J. W. 2008. Defeating pathogen drug resistance: guidance from evolutionary theory. Evolution62:3185-3191.
14. Price, G. R. 1970. Selection and covariance. Nature227:520-521.
15. Price, G. R. 1972. Extension of covariance selection mathematics. Annals of Human Genetics35:485-490.
16. Stewart, P. S. 2003. Diffusion in biofilms. Journal of Bacteriology185:1485-1491.
17. Wade, M. J. 1985. Soft selection, hard selection, kin selection, and group selection. American Naturalist125:61-73.
18. West, S. A., A. S. Griffin, and A. Gardner 2007. Social semantics: altruism, cooperation, mutualism, strong reciprocity and group selection. Journal of Evolutionary Biology20:415-432.